| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on May 29, 2007
Accepted on March 28, 2008
Molecular Endocrinology Group, Laboratory of Signal Transduction, NIEHS/NIH, DHHS, 111 T.W. Alexander Drive, Research Triangle Park, NC 27709
* To whom correspondence should be addressed. E-mail: cidlows1{at}niehs.nih.gov.
The glucocorticoid receptor (GR) mediates virtually all actions of glucocorticoids, and the nature and magnitude of a cell's response to these steroids are determined primarily by hormone concentration and GR signaling capacity. DAX-1 is an orphan nuclear receptor that functions as a corepressor and deletion or mutation of DAX-1 also causes a decrease in glucocorticoid production. However it is unclear if DAX-1 also alters GR function as a transcription factor. Here, we demonstrate that DAX-1 acts as a novel selective GR modulator. It specifically inhibits ligand-dependent GR transactivation with little effect on GR-mediated transrepression. As demonstrated by co-immunoprecipitation and glutathione-S-transferase pull down assays, DAX-1 physically interacts with GR, but this interaction does not influence either ligand-induced GR nuclear translocation or subsequent GR association with glucocorticoid responsive elements. Instead, DAX-1 competes with coactivators such as GRIP1 for binding to the receptor. Specifically, suppression of GR transactivation is mediated by the N-terminal half of DAX-1, and in particular the LXXLL motifs. Thus we demonstrate that DAX-1 directly modulates GR signaling in addition to affecting glucocorticoid hormone levels.
NURSA Molecule Pages Link:
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |